Immunoprotectivity of Salmonella enterica serovar Enteritidis virulence protein, InvH, against Salmonella typhi

Document Type : Original Article


1 Department of Biology, Shahed University, Tehran, Iran

2 Department of Biology, and Molecular Microbiology Research Center, Shahed University, Tehran, Iran

3 Department of Pathology, School of Medicine, Shahed University, Tehran, Iran

4 Department of Microbiology, School of Medicine, and Molecular Microbiology Research Center, Shahed University, Tehran, Iran

5 School of Medicine, Shahed University, Tehran, Iran


Objective(s):Typhoid fever is a dreadful disease of a major threat to public health in developing countries. Vaccination with bacterial immunodominant components such as surface proteins may prove as a potent alternative to live attenuated vaccines. InvH, an important part of needle complex in type three secretion system (TTSS) plays important role in efficient bacterial adherence and entry into epithelial cells.
Materials and Methods:In this work we used a 15 kDa recombinant InvH protein of Salmonella enteric serovar Enteritidis to provoke antibody production in mouse. The mice were immunized by recombinant InvH and challenged with Salmonella typhi. Histopathology of spleen and liver were studied.
Results:The immunized mice showed a significant rise of antibody after the second booster. The immunization induced protection against high doses of S. typhi. The bacterial challenge with sera showed significant protection against challenge dose of 2×109 CFU. Immunized sera reacted with          S. typhi markedly. Immunoreaction of bacterially infected sera and InvH protein was significantly higher than the control group. Bacterial loads of S. typhi in spleen was more than liver. Decreased bacterial load was evident in immunized mice after 7 days. Histological examination of the liver showed the immunized mice liver remained unaffected.
Conclusion: Efficacy of the virulence protein, InvH, in inhibition of this phenomenon by active immunization was shown here. It may be concluded that InvH, as an antigen, can develop protection against S. typhi infections. InvH may be exploited in protective measures as well as a diagnostic tool in Salmonella infections.


1.Mills-Robertson F, Addy ME, Mensah P, Crupper SS. Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. FEMS Microbiol Lett 2002; 215:249-253.
2.Aziah I, Ravichandran M, Ismail A. Amplification of ST50 gene using dry-reagent-based polymerase chain reaction for the detection of Salmonella typhi. Diagn Microbiol Infect Dis 2007; 59: 373-377.
3.Mandal S, Mandal MD, Pal NK. Enhancing chloramphenicol and trimethoprim in vitro activity by Ocimum sanctum Linn. (Lamiaceae) leaf extract against Salmonella enterica serovar Typhi. Asian Pac J of Trop Med 2012; 5:220-224.
4.Xie X, Li A, Du H, Sheng X, Zhang H, Xu S, et al. Expression of tviA  is transiently repressed by Hfq in Salmonella enterica serovar Typhi at hyperosmotic stress. Microb Pathog 2010; 49:54-57.
5.Kumar A, Arora V, Bashamboo A, Ali S. Detection of Salmonella typhi by polymerase chain reaction: implications in diagnosis of typhoidfever. Infect Genet Evol 2002; 2:107-110.
6.Paliwal PK, Bansal A, Sagi SSK, Mustoori S, Govindaswamy I. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice. Clin Immunol 2008; 126:89-96.
7.Spano S, Ugalde JE, Galon JE. Delivery of a Salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe 2008; 3:30-38.
8.Zhao L, Ezaki T, Li ZY, Kawamura Y, Hirose K, Watanabe H. Vi-Suppressed wild strain Salmonella typhi cultured in high osmolarity is hyperinvasive toward epithelial cells and destructive of Peyer's patches. Microbiol Immunol 2001; 45:149-158.
9.Kotton CN, Lankowski AJ, Scott N, Sisul D, Chen LM, 
Raschke K, et al. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine 2006; 24:6216-6224.
10. Liu SL, Ezaki T, Miura H, Matsui K, Yabuuchi E. Intact motility as a Salmonella typhi invasion-related factor. Infect Immun. 1988; 56:1967-1973.
11. Altmeyer RM, McNern JK, Bossio JC, Rosenshine I, Finlay BB, Galon JE. Cloning and molecular characterization of a gene involved in Salmonella adherence and invasion of cultured epithelial cells. Mol Microbiol. 1993; 7:89-98.
12. Gallois A, Klein JR, Allen LA, Jones BD, Nauseef WM. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol 2001; 166:5741-5748.
13. Galan J, Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006; 444:567-573.
14. Daefler S, Russel M. The Salmonella typhimurium InvH protein is an outer membrane lipoprotein required for the proper localization of InvG. Mol Microbiol 1998; 28:1367-1380.
15.Watson PR, Galyov EE, Paulin SM, Jones PW, Wallis TS. Mutation of invH, but Notstn, reduces Salmonella-induced enteritis in Cattle. Infect Immun 1998; 66:1432-1438.
16. Kimbrough TG, Miller SI. Assembly of the type III secretion needle complex of Salmonella typhimurium. Microbes Infect. 2002; 4:75-82.
17. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals, 8th edition. Washington (DC): National Academies Press (US); 2011.
18.Desin TS, Wisner AL, Lam PK, Berberov E, Mickael CS, Potter AA, et al. Evaluation of Salmonella enterica serovar Enteritidis pathogenicity island-1 proteins as vaccine candidates against Salmonella enteritidis challenge in chickens. Vet Microbiol 2011; 148:298-307.
19.Litrup E, Torpdahl M, Malorny B, Huehn S, Christensen H, Nielsen EM. Association between phylogeny, virulence potential and serovars of Salmonella enterica. Infect Genet Evol 2010; 10:1132-1139.
20.Methner U, Barrow PA, Berndt A, Rychlik I. Salmonella Enteritidis with double deletion in phoPfliC--a potential live Salmonella vaccine candidate with novel characteristics for use in chickens. Vaccine 2011; 29:3248-3253.